BrightGene Bio-Medic...
SHSE:688166
¥ 48,47
¥-1,15 (-2,32%)
48,47 ¥
¥-1,15 (-2,32%)
End-of-day quote: 03/31/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥0,43
Earnings Per Share
¥2,75
Revenue Per Share
100,00%
Gross Margin %
¥20,97 B
Market Cap
¥1,62 B
Long-Term Debt
Earnings Per Share
¥0,43
Revenue Per Share
¥2,75
Gross Margin %
100,00%
Market Cap
¥20,97 B
Long-Term Debt
¥1,62 B

Financials

Year Year 2025 2024 2023 2021 2020 2019
EPS Earnings Per Share ¥0,45 ¥0,45 ¥0,47 ¥0,59 ¥0,41 ¥0,27
Earnings Earnings ¥210,06M ¥189,95M ¥198,39M ¥241,90M ¥168,10M ¥110,70M
RPS Revenue Per Share ¥2,75 ¥3,04 ¥0,00 ¥2,57 ¥1,92 ¥1,23
Revenue Revenue ¥1,28B ¥1,28B ¥0,00M ¥1,05B ¥785,38M ¥503,16M
OCF Operating Cash Flow ¥245,56M ¥245,56M ¥0,00M ¥176,08M ¥155,43M ¥61,33M
FCF Free Cash Flow ¥0,00M ¥-11,34M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OM Operating Margin 1,32% 15,65% 17,65% 23,68% 23,31% 21,45%
GM % Gross Margin % 100,00% 56,30% 53,97% 55,33% 53,73% 62,78%
FCFS Free Cash Flow Per Share ¥0,00 ¥-0,03 ¥-0,50 ¥-1,80 ¥-0,48 ¥-0,08
LT Debt Long-Term Debt N/A ¥1,58B N/A N/A N/A N/A
Sha. Stocks 466,81M 422,11M 422,1M 410M 410M 410M
×